rs79913182

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_139318.5(KCNH5):​c.2315A>G​(p.Glu772Gly) variant causes a missense change. The variant allele was found at a frequency of 0.000337 in 1,614,210 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0017 ( 1 hom., cov: 33)
Exomes 𝑓: 0.00019 ( 0 hom. )

Consequence

KCNH5
NM_139318.5 missense

Scores

7
12

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 4.53

Publications

3 publications found
Variant links:
Genes affected
KCNH5 (HGNC:6254): (potassium voltage-gated channel subfamily H member 5) This gene encodes a member of voltage-gated potassium channels. Members of this family have diverse functions, including regulating neurotransmitter and hormone release, cardiac function, and cell volume. This protein is an outward-rectifying, noninactivating channel. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2013]
KCNH5 Gene-Disease associations (from GenCC):
  • infantile-onset epilepsy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy 112
    Inheritance: AD Classification: STRONG Submitted by: G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069195926).
BP6
Variant 14-62708160-T-C is Benign according to our data. Variant chr14-62708160-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 416117.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00173 (263/152316) while in subpopulation AFR AF = 0.00585 (243/41562). AF 95% confidence interval is 0.00524. There are 1 homozygotes in GnomAd4. There are 127 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 263 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNH5NM_139318.5 linkc.2315A>G p.Glu772Gly missense_variant Exon 11 of 11 ENST00000322893.12 NP_647479.2 Q8NCM2-1
KCNH5NM_172375.3 linkc.*282A>G 3_prime_UTR_variant Exon 10 of 10 NP_758963.1 Q8NCM2-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNH5ENST00000322893.12 linkc.2315A>G p.Glu772Gly missense_variant Exon 11 of 11 1 NM_139318.5 ENSP00000321427.7 Q8NCM2-1
KCNH5ENST00000420622.6 linkc.*282A>G 3_prime_UTR_variant Exon 10 of 10 1 ENSP00000395439.2 Q8NCM2-2

Frequencies

GnomAD3 genomes
AF:
0.00173
AC:
263
AN:
152198
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00586
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000785
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.000505
AC:
127
AN:
251484
AF XY:
0.000375
show subpopulations
Gnomad AFR exome
AF:
0.00541
Gnomad AMR exome
AF:
0.000809
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000791
Gnomad OTH exome
AF:
0.000326
GnomAD4 exome
AF:
0.000192
AC:
281
AN:
1461894
Hom.:
0
Cov.:
48
AF XY:
0.000179
AC XY:
130
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.00505
AC:
169
AN:
33480
American (AMR)
AF:
0.000850
AC:
38
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000369
AC:
41
AN:
1112012
Other (OTH)
AF:
0.000513
AC:
31
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
20
39
59
78
98
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00173
AC:
263
AN:
152316
Hom.:
1
Cov.:
33
AF XY:
0.00170
AC XY:
127
AN XY:
74492
show subpopulations
African (AFR)
AF:
0.00585
AC:
243
AN:
41562
American (AMR)
AF:
0.000784
AC:
12
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68030
Other (OTH)
AF:
0.00189
AC:
4
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000642
Hom.:
0
Bravo
AF:
0.00194
ESP6500AA
AF:
0.00681
AC:
30
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.000601
AC:
73
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000237

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Feb 18, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.2315A>G (p.E772G) alteration is located in exon 11 (coding exon 11) of the KCNH5 gene. This alteration results from a A to G substitution at nucleotide position 2315, causing the glutamic acid (E) at amino acid position 772 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Developmental and epileptic encephalopathy Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.099
BayesDel_addAF
Benign
-0.14
T
BayesDel_noAF
Uncertain
0.030
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.17
T
Eigen
Benign
0.030
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Benign
0.76
T
M_CAP
Uncertain
0.087
D
MetaRNN
Benign
0.0069
T
MetaSVM
Uncertain
0.78
D
MutationAssessor
Benign
0.55
N
PhyloP100
4.5
PrimateAI
Uncertain
0.56
T
PROVEAN
Benign
-1.3
N
REVEL
Uncertain
0.56
Sift
Benign
0.22
T
Sift4G
Benign
0.16
T
Polyphen
0.42
B
Vest4
0.22
MVP
0.67
MPC
0.13
ClinPred
0.010
T
GERP RS
5.4
Varity_R
0.12
gMVP
0.38
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs79913182; hg19: chr14-63174878; API